Greenwich LifeSciences
GLSI
15 hedge funds and large institutions have $4.08M invested in Greenwich LifeSciences in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
407,429% more capital invested
Capital invested by funds: $1K → $4.08M (+$4.07M)
1,400% more funds holding
Funds holding: 1 → 15 (+14)
0.88% more ownership
Funds ownership: 0% → 0.88% (+0.88%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$865K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$165K |
| 3 |
SW
SkyOak Wealth
Southfield,
Michigan
|
+$118K |
| 4 |
Millennium Management
New York
|
+$105K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$103K |
Top Sellers
GLSI Hedge Fund Activity: Q4 2020 in Review
15 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2020, worth a combined $4.08M — up 407,429% from $1K a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new GLSI positions and 0 closed out — a net gain of 14 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $865K.
- 15 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2020, up from 1 in Q3 2020.
- Funds reported $4.08M of Greenwich LifeSciences stock for Q4 2020, up 407,429% quarter-over-quarter.
- 14 funds opened new Greenwich LifeSciences positions in Q4 2020 and 0 closed out, a net change of +14 holders.
- The largest Greenwich LifeSciences buyer in Q4 2020 was BlackRock, an estimated $865K added.
Based on aggregated 13F filings for Q4 2020.